AngioDynamics ANGO Additional Paid-In Capital
Additional Paid-In Capital at other companies
Other financials
Where this comes from
Reported directly by AngioDynamics in its filing.
Tagged under the XBRL concept us-gaap:AdditionalPaidInCapitalCommonStock.
The official record: AngioDynamics’s 10-Q, filed April 2, 2026, on SEC EDGAR. View the filing →
Ask your AI about AngioDynamics's additional paid-in capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AngioDynamics's additional paid-in capital?
- AngioDynamics (ANGO) reported additional paid-in capital of $632.18M in Q4 2025.
- How has AngioDynamics's additional paid-in capital changed year-over-year?
- AngioDynamics's additional paid-in capital increased by 2.0% year-over-year, from $619.55M to $632.18M.
- What is the long-term trend for AngioDynamics's additional paid-in capital?
- Over 4 years (2021 to 2025), AngioDynamics's additional paid-in capital has grown at a 2.0% compound annual growth rate (CAGR), from $573.51M to $621.19M.
- What does additional paid-in capital mean?
- This represents the excess amount paid by investors for common shares over their par value. It is a key component of shareholders' equity that captures the capital raised through equity offerings beyond the nominal value of the stock. It reflects the historical market premium at which the company has issued its shares.